Testing effectiveness (Phase 2)Looking for participantsNCT06919003
What this trial is testing
Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
Who this might be right for
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 180